Bioptigen

About:

Bioptigen is a medical device company that develops innovative ophthalmic imaging equipment and software.

Website: http://bioptigen.com

Twitter/X: sdoct

Description:

Bioptigen Inc. is an ISO 13485-certified medical device company that develops innovative ophthalmic imaging solutions. Bioptigen’s Envisu(tm) R-class systems are ideally suited to non-invasive ophthalmic imaging of animals ranging from zebrafish to elephants. Using low-power, near-infrared light, Envisu generates real-time, high-resolution, volumetric images of ocular microstructures from the cornea to the retina. Bioptigen has received CE approval to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical use within the EU.

Total Funding Amount:

$1.5M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2004-01-01

Contact Email:

jvance(AT)bioptigen.com

Founders:

Joseph A. Izatt

Number of Employees:

11-50

Last Funding Date:

2011-03-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai